Are you or someone you know battling Chronic Inflammatory Response Syndrome (CIRS)? Prepare to embark on a transformative journey with our latest clinical trial at The Biologix Center for Optimum Health.
About the Study:
Backed by IRB support, our study aims to replicate early positive outcomes consistently. We’re dedicated to reducing or eliminating the underlying fungal mycotoxins, actinomycetes, microbial endotoxins, and lipopolysaccharides (LPS) causing CIRS.
Treatment Details:
- Receive comprehensive treatments and supportive therapies daily (Monday to Friday).
- Undergo a one-to-two-week program of care, with virtual follow-up appointments.
- Experience a tailored approach with induced native phage therapy, a safe and non-allergenic treatment.
Goal:
Our primary goal is to identify and neutralize the causative agents of CIRS, paving the way for symptom alleviation and improved quality of life.
Prerequisites:
Recent laboratory test results demonstrating high fungal mycotoxins and a commitment to retesting post-treatment.